Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1969 2
1970 3
1971 11
1972 11
1973 6
1974 8
1975 5
1976 11
1977 13
1978 7
1979 18
1980 22
1981 30
1982 41
1983 27
1984 31
1985 41
1986 48
1987 52
1988 62
1989 69
1990 100
1991 93
1992 162
1993 217
1994 195
1995 185
1996 377
1997 464
1998 447
1999 485
2000 476
2001 492
2002 453
2003 452
2004 522
2005 543
2006 514
2007 527
2008 494
2009 452
2010 463
2011 474
2012 469
2013 428
2014 417
2015 401
2016 386
2017 370
2018 385
2019 181
2020 9
Text availability
Article attribute
Article type
Publication date

Search Results

11,226 results
Results by year
Filters applied: . Clear all
Page 1
Alectinib.
Herden M, Waller CF. Herden M, et al. Recent Results Cancer Res. 2018;211:247-256. doi: 10.1007/978-3-319-91442-8_17. Recent Results Cancer Res. 2018. PMID: 30069772 Review.
Ondansetron clinical pharmacokinetics.
Roila F, Del Favero A. Roila F, et al. Clin Pharmacokinet. 1995 Aug;29(2):95-109. doi: 10.2165/00003088-199529020-00004. Clin Pharmacokinet. 1995. PMID: 7586904 Review.
Neuroprotective efficacy of P7C3 compounds in primate hippocampus.
Bauman MD, Schumann CM, Carlson EL, Taylor SL, Vázquez-Rosa E, Cintrón-Pérez CJ, Shin MK, Williams NS, Pieper AA. Bauman MD, et al. Transl Psychiatry. 2018 Sep 26;8(1):202. doi: 10.1038/s41398-018-0244-1. Transl Psychiatry. 2018. PMID: 30258178 Free PMC article.
Midostaurin: First Global Approval.
Kim ES. Kim ES. Drugs. 2017 Jul;77(11):1251-1259. doi: 10.1007/s40265-017-0779-0. Drugs. 2017. PMID: 28612232 Review.
Targeting molecular pathways in cancer stem cells by natural bioactive compounds.
Cianciosi D, Varela-Lopez A, Forbes-Hernandez TY, Gasparrini M, Afrin S, Reboredo-Rodriguez P, Zhang J, Quiles JL, Nabavi SF, Battino M, Giampieri F. Cianciosi D, et al. Pharmacol Res. 2018 Sep;135:150-165. doi: 10.1016/j.phrs.2018.08.006. Epub 2018 Aug 10. Pharmacol Res. 2018. PMID: 30103002 Review.
From Quinoxaline, Pyrido[2,3-b]pyrazine and Pyrido[3,4-b]pyrazine to Pyrazino-Fused Carbazoles and Carbolines.
Lassagne F, Langlais T, Caytan E, Limanton E, Paquin L, Boullard M, Courtel C, Curbet I, Gédéon C, Lebreton J, Picot L, Thiéry V, Souab M, Baratte B, Ruchaud S, Bach S, Roisnel T, Mongin F. Lassagne F, et al. Molecules. 2018 Nov 13;23(11):2961. doi: 10.3390/molecules23112961. Molecules. 2018. PMID: 30428591 Free PMC article.
Neurotherapeutic capacity of P7C3 agents for the treatment of Traumatic Brain Injury.
Blaya MO, Wasserman JM, Pieper AA, Sick TJ, Bramlett HM, Dietrich WD. Blaya MO, et al. Neuropharmacology. 2019 Feb;145(Pt B):268-282. doi: 10.1016/j.neuropharm.2018.09.024. Epub 2018 Sep 17. Neuropharmacology. 2019. PMID: 30236963 Free PMC article. Review.
11,226 results
Jump to page
Feedback